Mindful Innovation
Mastering Challenges. Compassion for Patients. Transforming Medicine.
At Marinus Pharmaceuticals, our passionate team of experts is constantly innovating with the aim to drastically improve lives affected by seizure disorders.
Marinus is committed to improving the lives of patients living with seizure disorders. We are developing an investigational drug, ganaxolone, which is an innovative and much needed potential treatment option for children and adults.
At Marinus, we use a strong scientific rationale, determination, and expertise to embrace the challenge of developing treatments for seizure disorders. We are committed to our patients, physicians, and epilepsy community, as we plan our path forward to providing much needed options for patients.
Our vision is to strengthen the value of ganaxolone as a first-in-class innovative therapy for children and adults afflicted with seizure disorders.
At Marinus
We are committed to creating a diverse and inclusive culture that provides an environment of mutual respect and accountability and where equal employment opportunities are available to all.
Our Philosophy
We are dedicated and talented professionals, valued for our innovation and commitment to developing new therapies for our patient communities.
Great benefits to support great talent
We know employees work best when they are supported professionally and personally. Our carefully crafted benefits package is aimed at helping employees maintain a high quality of life and cover your overall health and well-being.
We are always looking for dedicated and passionate professionals who want to make a positive difference in the lives of those affected by seizure disorders
Without a focus on diversity and a commitment to equality for all, there is no moving forward.
- Rose McKinley, VP of Human Resources & Organizational Development